ELV · 10-Q · 2026Q2 · Full report

Liquidity and Cash Position

Elevance Health, Inc. · 2026-07-15 · Importance 54 · Surprise 14 · In source text

Elevance reported consolidated cash, cash equivalents and investments in fixed maturity and equity securities of $38,773 at June 30, 2026, an increase of $1,537 since December 31, 2025, driven primarily by increased cash generated from operations and decreased net debt repayments. The company held $2,062 of cash, cash equivalents and investments at the parent company available for general corporate use, including acquisitions, share repurchases and dividends. Management states that cash on hand, operating cash receipts, investments and available committed facilities (commercial paper, the 5-Year Facility and FHLB borrowings) are expected to be adequate to fund expected cash disbursements over the next twelve months. The company also notes periodic access to capital markets and a shelf registration for future debt or equity offerings for general corporate purposes.

Key facts

• Consolidated cash, cash equivalents and investments in fixed maturity and equity securities were $38,773 at June 30, 2026. source
• At June 30, 2026, the parent company held $2,062 of cash, cash equivalents and investments available for general corporate use. source
• Since December 31, 2025, total cash, cash equivalents and investments in fixed maturity and equity securities increased by $1,537 primarily due to increased cash generated from operations and decreased cash used in repayment of short- and long-term debt, net of issuances. source

Impact estimates